medication reforms

Mid-Atlantic States Move to Restrict Use of Clenbuterol

Continuing a decades-long regional effort to enact uniform medication, safety and welfare reforms, protocols and rules, a coalition of 31 regulatory and stakeholder organizations representing all seven states in the Mid-Atlantic region have unanimously agreed to work together to implement a new rule that will significantly restrict the improper use of the bronchodilator clenbuterol. Under the current regional rule, clenbuterol may not be administered to a horse within 14 days of a race, and the concentration of the drug in a post-race blood sample may not exceed 140 picograms/ml. The...

[ Read More ]
Horseracing Integrity and Safety Act Passes House

By a unanimous Sep. 29 voice vote, the United States House of Representatives passed a years-in-the-making bill that, if eventually signed into law, will develop and implement anti-doping, medication control, drug testing, and racetrack safety standard programs enforced by an independent authority whose powers would supersede the long-standing state-by-state regulation of the sport. HR 1754, which has existed in various proposed forms since 2015 and was amended Sep. 9 to match the Horseracing Integrity and Safety Act (HISA) companion legislation that got introduced in the U.S. Senate that same day,...

[ Read More ]
Two Defendants in Federal Indictment Plead Guilty to Doping Charges

Scott Robinson and Sarah Izhaki each pled guilty today to conspiring to unlawfully distribute adulterated and misbranded drugs for the purpose of doping racehorses. Robinson pled guilty before U.S. District Judge J. Paul Oetken, and will be sentenced by Judge Oetken Jan. 15, 2021. Izhaki pled guilty before U.S. District Judge Mary Kay Vyskocil, and will be sentenced by Judge Vyskocil Dec. 2, 2020. The guilty pleas are the first major domino to fall from the bombshell FBI indictments that the U.S. Attorney's Office for the Southern District of New...

[ Read More ]
Keeneland, Fasig-Tipton and OBS Announce Major Reforms to Medication and Riding Crop Policies for 2-Year-Old Sales

Officials from Keeneland Association, Fasig-Tipton Company Inc. and Ocala Breeders' Sales Company Inc. have jointly announced significant changes to policies regarding medication, including restriction of non-steroidal anti-inflammatory drugs (NSAIDs) and a ban on bronchodilators at all 2-year-old sales, and limited use of riding crops at under-tack shows. The revised Conditions of Sale for each sales company take effect March 2020. These proactive measures demonstrate continued uniformity among the United States' three largest Thoroughbred auction houses and are the latest round of leadership reforms undertaken in recent years, following action in...

[ Read More ]